Boulevard reviews the latest media coverage of the Oscar-winning Louisville native in our exclusive Jennifer Lawrence Diary™. Today’s news, rated on a scale of 1-5 stars:
Multiple offers are already on the table for the drama starring Jennifer Lawrence, about controversial Silicon Valley entrepreneur Elizabeth Holmes. And that’s even before a round of pitches Monday as director Adam McKay nears a final decision, according to Deadline.
The Hollywood trade publication revealed only last week that Lawrence and McKay would be teaming on the project, and a package of background materials was sent to numerous buyers just yesterday morning.
The sizzling competition among producers is hardly surprising. Lawrence, 25, is Hollywood’s most bankable star, and McKay won an Oscar this year for co-writing and directing another hot-button film, The Big Short.
Deadline’s got the background:
Holmes, 32, launched Theranos in 2003, with claims it could test blood with only a pinprick vs. the traditional method of drawing blood by injection. That pumped up the company’s valuation to $9 billion as recently as two years ago. The company has since come under investigation over claims of inaccurate testing. And Holmes’ own worth — at one point valued at $4.5 billion for her 50% stake — has fallen to a fraction of that.